Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery

Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.

In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.

 

whitepaper image
download icon

Download whitepaper

Genetics in focus: Addressing the complexities of genetic eye disease and patient care

As genetic research continues to advance, understanding and addressing the complexities of genetic eye diseases has become crucial for improving patient outcomes. This whitepaper, written in collaboration with 20/20 Onsite and Clinical Enrollment, explores the latest advancements in genetic eye disease research, examines the growing impact of emerging therapies on patient care, and highlights the need for multidisciplinary partnerships to continue to drive this research forward.

Group 48096112-1

 

What you’ll find inside:

🔬 The role of genetics in eye disease: How genetic variations impact eye health and contribute to conditions such as Fuchs' dystrophy, keratoconus, congenital cataracts, and more.
👁️ Inherited retinal disorders (IRDs): A closer look at IRDs, including retinitis pigmentosa, Stargardt disease, and Leber congenital amaurosis (LCA), and how groundbreaking gene therapies like Luxturna are transforming treatment options.
💊 Challenges in developing new therapies: Exploring the hurdles faced in the development of treatments for rare and complex genetic eye conditions, including barriers to diagnosis, patient identification, and access to care.
📈 The future of genetic eye disease treatment: From new diagnostic technologies to the importance of public awareness and global collaboration, learn how the landscape is evolving for patients, researchers, and healthcare providers.

Download to explore how cutting-edge genetic research is shaping the future of eye disease diagnosis, care, and treatment.